Aspira Women’s Health News and Activities

Aspira Women’s Health is a company listed under the stock ticker AWH (US).

View the org chart displaying its 15 main executives

Most searched biographies at Aspira Women’s Health

• Jack Fraser, Interim Chief Executive Officer and Chairman of the B...
• Jeffrey Cohen, Director
• Jane Wood, Director

Popular executive movements at Aspira Women’s Health

• Jack Fraser who was Chairman of the Board, becomes Interim Chief Executive Officer and Chairman of the Board  (posted on June 23 2026).
• Mike Buhle, Chief Executive Officer, has left the company  (posted on June 23 2026).
• John Strahley has joined the company as Chief Financial Officer  (posted on May 31 2026).

Create your alert
to follow the executive moves at Aspira Women’s Health.

Aspira Women’s Health has 1,245 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Medtronic (Ireland).

Popular M&A news in Medical Equipment

• CVC Capital Partners has announced the acquisition of WillowWood  (posted on June 18 2026).
• Spectrum Vascular has acquired Piccolo Medical (posted on June 17 2026).
• Medtronic has acquired Scientia Vascular (posted on June 14 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific

Learn more about the Medical Equipment industry

Press releases by Aspira Women’s Health

• Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results – Aspira Women's Health
• Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® – Aspira Women's Health
• Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024 – Aspira Women's Health
• Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health – Aspira Women's Health
• Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024 – Aspira Women's Health
• Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch® – Aspira Women's Health
• Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass – Aspira Women's Health
• Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference – Aspira Women's Health
• View more press releases Close

Social media about Aspira Women’s Health

• Aspira Women’s Health on Wikipedia, Google News & Yahoo Finance
• Aspira Women’s Health on LinkedIn, X (Twitter) & YouTube